https://www.taxtmi.com/news?id=72213 Indian pharmaceutical exports recorded sustained growth in FY26, reaching nearly USD 29 billion by the end of February and increasing over the corresponding period in the previous financial year. The export performance was led by formulations, biologicals, vaccines and Ayush products, and was described as resilient despite global challenges, pricing pressures and trade volatility. The sector's overall value was placed at about USD 60 billion, with projected expansion to USD 130 billion by 2030. en-us Sat, 04 Apr 2026 12:01:02 +0530 Sat, 04 Apr 2026 12:01:02 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=72213 Indian pharmaceutical exports recorded sustained growth in FY26, reaching nearly USD 29 billion by the end of February and increasing over the corresponding period in the previous financial year. The export performance was led by formulations, biologicals, vaccines and Ayush products, and was described as resilient despite global challenges, pricing pressures and trade volatility. The sector's overall value was placed at about USD 60 billion, with projected expansion to USD 130 billion by 2030. News - Sat, 04 Apr 2026 12:01:02 +0530 https://www.taxtmi.com/news?id=72213